Skip to main content
SpringerLink
Log in

Theoretical and therapeutic considerations for the anxiety disorders

  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

Everyone is familiar with that paralyzing state of dread known as anxiety. Although it is unpleasant, the experience of anxiety has adaptive aspects: it can serve as an impetus to effect beneficial life change and can facilitate psychological development. Anxiety becomes of clinical concern, however, when it interferes with intellectual function, or arrests normal social or vocational pursuits.

Anxiety disorders are chronic illnesses. Treatment can eliminate many of the disease's debilitating features, but the underlying disorder is not usually cured. Discontinuation of treatment—pharmacological, behavioral, or both—often results in the recurrence of symptoms. The focus of treatment, therefore, generally centers on striking a balance between the goal of alleviating the patient's symptoms, and the need to avoid the deleterious effects which result from long-term treatment (1).

The intention of this paper is to review theoretical and therapeutic considerations for four types of anxiety disorder: panic disorder, generalized anxiety disorder, social phobia, and obsessive-compulsive disorder. In doing this, emphasis will be placed on the physiological concomitants and, when possible, neuropsychological bases of these illnesses. Furthermore, pharmacological treatment will be related to the underlying substrata of the disorder whenever possible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gorman JM, Papp LA: Chronic anxiety: deciding the length of treatment. Journal of Clinical Psychiatry 51:11–15 (suppl), 1990.

    Google Scholar 

  2. Klein DF: Anxiety reconceptualized, in Anxiety: New Research and Changing Concepts. Edited by Klein DF, Rabkin JG. New York, Raven Press, 1981.

    Google Scholar 

  3. Uhde TW, Boulenger JP, Roy-Byrne PP, et al: Longitudinal course of panic disorder: clinical and biological considerations. Neuropharmacological and Biological Psychiatry 9:39–51, 1985.

    Google Scholar 

  4. Cloninger CR, Martin RL, Clayton P, et al: A blind follow-up and family study of anxiety neurosis: preliminary analysis of the St. Louis 500, in Anxiety: New Research and Changing Concepts. Edited by Klein DF, Rabkin JG. New York, Raven Press, 1981.

    Google Scholar 

  5. DeNardo PA, O'Brien GT, Barlow DH, et al: Reliability of DSM-III anxiety disorder categories using a new structured interview. Archives of General Psychiatry 40:1070–1078, 1984.

    Google Scholar 

  6. Brier A, Charney DS, Heninger GR: Agoraphobia with panic attacks: development, diagnostic stability and course of illness. Archives of General Psychiatry 43:1029–1036, 1986.

    Google Scholar 

  7. Leckman JF, Weissmann MM, Merikangas KR, et al: Panic disorder and major depression: increased risk of depression, alcoholism, panic and phobic disorders in families of depressed probands with panic disorder. Archives of General Psychiatry 40:1055–1060, 1983.

    Google Scholar 

  8. Kendler KS, Heath A, Martin MG, et al: Symptoms of anxiety and depression in a volunteer twin population. Archives of General Psychiatry 43:213–221, 1986.

    Google Scholar 

  9. Torgersen S: Genetic factors in anxiety disorders. Archives of General Psychiatry 40:1085–1089, 1983.

    Google Scholar 

  10. Noyes R, Crowe RR, Harris EL, et al: Relationship between anxiety and major depression. Archives of General Psychiatry 43:227–232, 1986.

    Google Scholar 

  11. Gorman JM, Liebowitz MR, Fyer AJ, et al: An open trial of fluoxetine in the treatment of panic attacks. Journal of Clinical Psychopharmacology 7:329–332, 1987.

    Google Scholar 

  12. Rifkin A, Klein DF, Dillon D, et al: Blockade by imipramine or desipramine of panic induced by sodium lactate. American Journal of Psychiatry 138:676–677, 1981.

    Google Scholar 

  13. Zitrin CM, Klein DF, Woerner MG, et al: Treatment of phobias I: comparison of imipramine hydrochloride and placebo. Archives of General Psychiatry 40:125–138, 1983.

    Google Scholar 

  14. Weissman MM, Klerman GL, Marowitz, et al: Suicidal ideation and suicidal attempts in panic disorder and attacks. New England Journal of Medicine 321:1209–1214, 1989.

    Google Scholar 

  15. Kushner MG, Sher KJ, Beitmen BD: The relation between alcohol problems and the anxiety disorders. American Journal of Psychiatry 147:685–695, 1990.

    Google Scholar 

  16. Nesse RM, Cameron OG, Curtis GC: Adrenergic function in patients with panic anxiety. Archives of General Psychiatry 41:771–776, 1984.

    Google Scholar 

  17. Gorman JM, Liebowitz MR, Fyer AJ, et al: A neuroanatomical hypothesis for panic disorder. American Journal of Psychiatry 146 (2):148–161, 1989.

    Google Scholar 

  18. Kelly D, Mitchell-Heggs N, Shean D: Anxiety and the effects of sodium lactate assessed clinically and physiologically. British Journal of Psychiatry 119:129–141, 1971.

    Google Scholar 

  19. Roy-Byrne PP, Uhde TW, Post RM, et al: Normal pain sensitivity in patients with panic disorder. Psychiatry Research 14:75–82, 1985.

    Google Scholar 

  20. Charney DS, Heninger GR: Abnormal regulation of noradrenergic function in panic disorders. Archives of General Psychiatry 43:1042–1054, 1986.

    Google Scholar 

  21. Liebowitz MR, Gorman JM, Fyer AJ, et al: Possible mechanisms for lactate's induction of panic. American Journal of Psychiatry 143:495–502, 1986.

    Google Scholar 

  22. Charney DS, Heninger GR, Redmond DE: Yohimbine induces anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sciences 33:19–29, 1983.

    Google Scholar 

  23. Charney DS, Heninger GR, Jatlow PI: Increased anxiogenic effects of caffeine in panic disorders. Archives of General Psychiatry 42:233–243, 1985.

    Google Scholar 

  24. Woods SW, Charney DS, Lake J, et al: Carbon dioxide sensitivity to panic anxiety: ventilatory and anxiogenic response to carbon dioxide in healthy subjects and panic anxiety patients with agoraphobia and panic disorder. Archives of General Psychiatry 43:900–909, 1986.

    Google Scholar 

  25. Gorman JM, Fyer MN, Goetz R, et al: Ventilatory challenge studies of patients with panic disorder. Archives of General Psychiatry 45:31–39, 1988.

    Google Scholar 

  26. Rainey JM, Pohl RB, Williams M, et al: A comparison of lactate and isoproterenol anxiety states. Psychopathology 17 (suppl 1):74–82, 1984.

    Google Scholar 

  27. Pyke PE, Greenberg HS: Norepinephrine challenges in panic patients. Journal of Clinical Psychopharmacology 6:279–285, 1986.

    Google Scholar 

  28. Redmond DE: New and old evidence for the involvement of a brain norepinephrine system in anxiety, in Phenomenology and Treatment of Anxiety. Edited by Fann WE, Karacan I, Pokorny AD, et al. New York, SP Medical and Scientific Books, 1979.

    Google Scholar 

  29. Holmberg G, Gershon S: Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacology (Berlin) 2:93–106, 1961.

    Google Scholar 

  30. NcNaughton N, Mason ST: The neuropsychology and neuropharmacology of the dorsal ascending noradrenergic bundle: a review. Progress in Neurobiology 14:157–219, 1980.

    Google Scholar 

  31. Charney DS, Heninger GR, Breier A: Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Archives of General Psychiatry 41:751–763, 1984.

    Google Scholar 

  32. Liebowitz MR, Fyer AJ, Gorman JM, et al: Specificity of lactate infusions in social phobia versus panic disorder. American Journal of Psychiatry 142:947–950, 1985.

    Google Scholar 

  33. Gorman JM, Liebowitz MR, Fyer AJ, et al: Lactate infusions in obsessive compulsive disorder. American Journal of Psychiatry 142:864–866, 1985.

    Google Scholar 

  34. Cowley DS, Dager SR, Dunner DL: Lactate-induced panic in primary affective disorder. American Journal of Psychiatry 143:646–648, 1986.

    Google Scholar 

  35. Gray JA: The Neuropsychology of Anxiety: an Enquiry into the Function of the Septohippocampal System. New York, Oxford University Press, 1982.

    Google Scholar 

  36. Crowe RR, Noyes R, Samuelson S, et al: A linkage study of panic disorder. Archives of General Psychiatry 40:1065–1069, 1987.

    Google Scholar 

  37. Watson D, Clark LA: Negative affectivity: the disposition to experience aversive emotional states. Psychological Bulletin 96:465–490, 1984.

    Google Scholar 

  38. Fyer AJ, Sandberg D, Klein DF: Pharmacologic treatment of panic disorder and agoraphobia, in Annual Review of Psychiatry, vol 7. Edited by Frances AJ, Hales RE. Washington DC, American Psychiatric Press, 1988.

    Google Scholar 

  39. Spier SA, Tesar GE, Rosenbaum JF, et al: Treatment of panic disorder and agoraphobia with clonazepam. Journal of Clinical Psychiatry 47:238–242, 1986.

    Google Scholar 

  40. Dunner DL, Ishiki D, Avery DH, et al: Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study. Journal of Clinical Psychiatry 47:458–460, 1986.

    Google Scholar 

  41. Goldfried MR: Anxiety reduction through cognitive-behavioral intervention, in Cognitive-Behavioral Interventions: Theory, Research, and Procedures. Edited by Kendall PC, Hollon SD. Orlando, Academic Press, 1979.

    Google Scholar 

  42. Klosko JS, Barlow DH, Tassinary R, et al: A comparison of alprazolam and behavior therapy in the treatment of panic disorder. Journal of Consulting and Clinical Psychology 58:77–84, 1990.

    Google Scholar 

  43. Goldberg D: Detection and assessment of emotional disorders in a primary care setting. International Journal of Mental Health 8:30–48, 1979.

    Google Scholar 

  44. Wheeler EO, White PD, Reed EW, et al: Neurocirculatory asthenia (anxiety neurosis, effort syndrome, neurasthenia): A twenty-year follow-up study of one hundred and seventy-three patients. Journal of the American Medical Association 142:878–889, 1950.

    Google Scholar 

  45. Schweitzer L, Adams G: The diagnosis and management of anxiety for primary care physicians, in Phenomenology and Treatment of Anxiety. Edited by Fann WE, Karacan I, Polorny AD, et al. New York, SP Medical and Scientific Books, 1979.

    Google Scholar 

  46. Fuster JM: The Prefrontal Cortex: Anatomy, Physiology, and Neuropsychology of the Frontal Lobe. New York, Raven Press, 1980.

    Google Scholar 

  47. Barnes HN, Aronson MD, Delbanco TL: Alcoholism: A Guide for the Primary Care Physician. New York, Springer Verlag, 1987.

    Google Scholar 

  48. Selling LS: The clinical use of a new tranquilizing drug. Journal of the American Medical Association 157:594, 1955.

    Google Scholar 

  49. Gellhorn E: Motion and emotion: the role of proprioception in the physiology and pathology of the emotions. Psychological Review 71:457–472, 1964.

    Google Scholar 

  50. Jacobson E: Progressive Relaxation. Chicago, The University of Chicago Press, 1939.

    Google Scholar 

  51. Costa E: The allosteric modulation of the GABA-A receptor: seventeen years of research. Neuropsychopharmacology 4:225–235, 1991.

    Google Scholar 

  52. Insel TR, Ninan PT, Aloi J, et al: A benzodiazepine receptor-mediated model of anxiety: studies in non-human primates and clinical applications. Archives of General Psychiatry 41:741–750, 1984.

    Google Scholar 

  53. Watson JB: Behaviorism. New York, Norton, 1924.

    Google Scholar 

  54. Rachman S: Anxiety disorders: some emerging theories. Journal of Behavioral Assessment 6:281–299, 1984.

    Google Scholar 

  55. Weiss JM, Glazer HI, Pohorecky LA: Coping behavior and neurochemical changes: an alternative explanation for the original ‘learned helplessness’ experiments, in Animal Models of Human Psychobiology. Edited by Serban A, Kling A. New York, Plenum Press, 1976.

    Google Scholar 

  56. Gurvey MH, Tollefson GD: Prevalence of misuse of prescribed benzodiazepines in patients with primary anxiety or major depression. American Journal of Psychiatry 143:1601–1603, 1986.

    Google Scholar 

  57. Roy-Byrne PP, Hommer D: Benzodiazepine withdrawal: overview and implications for treatment of anxiety. American Journal of Medicine 84:1041–1052, 1988.

    Google Scholar 

  58. Rickels K, Schweitzer E, Csanalosi I, et al: Long-term treatment of anxiety and risk of withdrawal. Archives of General Psychiatry 45:444–450, 1988.

    Google Scholar 

  59. Rassmussen J, Tsuang MT: Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. American Journal of Psychiatry 143:317–322, 1986.

    Google Scholar 

  60. Robins LN, Helzer JE, Weissmann MM, et al: Lifetime prevalence of specific psychiatric disorders at three sites. Archives of General Psychiatry 41:949–959, 1984.

    Google Scholar 

  61. Pauls DL, Towbin KE, Leckman JF, et al: Gilles de la Tourette syndrome and obsessive-compulsive disorder. Archives of General Psychiatry 43:1180–1182, 1986.

    Google Scholar 

  62. Carey G, Gottesman II: Twin and family studies of anxiety, phobic, and obsessive disorder, in Anxiety: New Research and Changing Concepts. Edited by Klein DF, Rabkin J. New York, Raven Press, 1981.

    Google Scholar 

  63. Flament MF, Rapoport JL, Berg CJ, et al: Clomipramine treatment of childhood obsessive-compulsive disorder: a double-blind controlled study. Archives of General Psychiatry 42:977–986, 1985.

    Google Scholar 

  64. Hollander E, Fay M, Cohen B, et al: Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. American Journal of Psychiatry 145:1015–1017, 1988.

    Google Scholar 

  65. Hoehn-Saric R, Merchant AF, Keyser ML, et al: Effects of clonidine on anxiety disorders. Archives of General Psychiatry 38:1278–1282, 1981.

    Google Scholar 

  66. Hollander E, DeCaria C, Liebowitz MR: Biological aspects of obsessive-compulsive disorder. Psychiatric Annals 19:80–87, 1989.

    Google Scholar 

  67. McKeon I, McGuffin P, Robinson P: Obsessive-compulsive neurosis following head injury: a report of four cases. British Journal of Psychiatry 144:190–192, 1984.

    Google Scholar 

  68. Schilder P: The organic background of obsessions and compulsions. American Journal of Psychiatry 94:1397–1416, 1938.

    Google Scholar 

  69. Capstick N, Seldrup U: Obsessional states: a study in the relationship between abnormalities at birth and subsequent development of obsessional symptoms. Acta Psychiatrica Scandinavia 56:427–539, 1977.

    Google Scholar 

  70. Barton R: Diabetes insipidus and obsessional neurosis: a syndrome. Lancet 1:133–135, 1965.

    Google Scholar 

  71. Rapoport J, Elkins R, Langer DH, et al: Childhood obsessive-compulsive disorders. American Journal of Psychiatry 138:1545–1555, 1981.

    Google Scholar 

  72. Grimshaw L: Obsessional disorder and neurological illness. Journal of Neurology and Neurological Psychiatry 27:229–231, 1964.

    Google Scholar 

  73. Lewin W: Selective leukotomy: a review, in Surgical Approaches to Psychiatry. England, Medical and Technical Publishing Company, 1973.

    Google Scholar 

  74. Pacella BL, Polatin JC, Nagler SH: Clinical and EEG studies in obsessive-compulsive states. American Journal of Psychiatry 96:830–838, 1940.

    Google Scholar 

  75. Jenike MA, Brotman AW: The EEG in obsessive-compulsive disorder. Journal of Clinical Psychiatry 45:122–124, 1984.

    Google Scholar 

  76. Insel TR, Gillin JC, Moore A, et al: Sleep in obsessive-compulsive disorder. Biological Psychiatry 3:149–158, 1971.

    Google Scholar 

  77. Rapoport JL: The waking nightmare: an overview of obsessive-compulsive disorder. Journal of Clinical Psychiatry 51(suppl):25–28, 1990.

    Google Scholar 

  78. Thoren P, Asberg M, Cronholm B, et al: Clomipramine treatment of obsessive-compulsive disorder: a controlled clinical trial. Archives of General Psychiatry 37:1281–1285, 1980.

    Google Scholar 

  79. Turner SM, Jacob RG, Beidel D, et al: Fluoxetine treatment of obsessive-compulsive disorder. Journal of Clinical Psychopharmacology 5:207-, 1985.

    Google Scholar 

  80. Marks IM, Lelliot P, Basoglu M, et al: Clomipramine, self-exposure, and therapist-aided exposure for obsessive-compulsive rituals. British Journal of Psychiatry 152:522–534, 1988.

    Google Scholar 

  81. Pato MT, Zohar-Kadouch R, Zohar J, et al: Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. American Journal of Psychiatry 145:1521–1525, 1988.

    Google Scholar 

  82. Falloon IR, Lloyd GG, Harpin RE: The treatment of social phobia. Journal of Nervous and Mental Diseases 169:180–184, 1981.

    Google Scholar 

  83. Amies PL, Gelder MG, Shaw PM: Social phobia: a comparative clinical study. British Journal of Psychiatry 142:174–179, 1983.

    Google Scholar 

  84. Nichols KA: Severe social anxiety. British Journal of Medical Psychology 47:301–306, 1974.

    Google Scholar 

  85. Marks IM, Mishan J: Dysmorphophobia: a pilot study of behavioral treatment in disturbed bodily perception. British Journal of Psychiatry 152:674–678, 1988.

    Google Scholar 

  86. Kagan J, Reznik JS, Clark C, et al: Behavioral inhibition to the unfamiliar. Child Development 55:2212–2225, 1984.

    Google Scholar 

  87. Marks IM, Gelder MG: Different ages of onset in varieties of phobias. American Journal of Psychiatry 123:218–221, 1967.

    Google Scholar 

  88. Liebowitz MR, Gorman JM, Fyer AJ, et al: Social phobia: review of a neglected anxiety disorder. Archives of General Psychiatry 42:729–736, 1985.

    Google Scholar 

  89. Munjack DJ, Brown RA, McDowell DE: Comparison of social anxiety in patients with social phobia and panic disorder. Journal of Nervous and Mental Disease 175:49–51, 1987.

    Google Scholar 

  90. Edelman RJ: Dealing with embarrassing events: socially anxious and non-socially anxious groups compared. British Journal of Clinical Psychology 24:281–288, 1985.

    Google Scholar 

  91. Chambless DL, Cherney J, Caputo GC, et al: Anxiety disorders and alcoholism: a study with inpatient alcoholics. Journal of Anxiety Disorders 1:29–40, 1987.

    Google Scholar 

  92. Smail P, Canter P, Stockwell S, et al: Alcohol dependence and phobic anxiety states I. a prevalence study. British Journal of Psychiatry 144:53–57, 1984.

    Google Scholar 

  93. Rose RJ, Dilto WB: A developmental-genetic analysis of common fears from early adolescence to early adulthood. Child Development 54:361–368.

  94. Gorman JM, Gorman LK: Drug treatment of social phobia. Journal of Affective Disorders 13:183–192, 1987.

    Google Scholar 

  95. Reich J, Yates W: A pilot study of treatment of social phobia with alprazolam. American Journal of Psychiatry 145:590–594, 1988.

    Google Scholar 

  96. Matlick RP, Peters L: Treatment of social phobia: effects of guided exposure with and without cognitive restructuring. Journal of Consulting and Clinical Psychology 56:251–260, 1988.

    Google Scholar 

  97. Falloon IR, Lindley P, McDonald R, et al: Social skills training of out-patient groups: a controlled study of rehearsal and homework. British Journal of Psychiatry 131:599–609, 1977.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. the Department of Psychiatry, College of Physicians and Surgeons, Columbia University, 10032, New York, New York

    Levi Taylor Ph.D. & Jack Gorman M.D.

Authors
  1. Levi Taylor Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jack Gorman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, L., Gorman, J. Theoretical and therapeutic considerations for the anxiety disorders. Psych Quart 63, 319–342 (1992). https://doi.org/10.1007/BF01066762

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01066762

Keywords

Search

Navigation